Search results
4 sty 2023 · This Review summarizes the biology of uveal melanoma and the management of primary disease, including molecular risk classification, adjuvant therapy and follow-up strategies.
• The posterior uveal melanoma section in the latest edition of the AJCC Cancer Staging Manual includes a new subcategory to the N category that differentiates between patients with extrascleral extension and those with regional spread into the orbit not contiguous with the eye.
The Melanoma Focus guideline for Uveal Melanoma (UM) was started in 2012 and published in 2015. A review and update of that guideline was started in 2020 and completed in 2022. Sections where practice or treatment had changed to such an extent that the 2015 recommendations were out-of-date, were identified and updated.
1 wrz 2023 · The prognosis is pejorative and considers clinical, tumor anatomy, histological and molecular parameters. This review provides a broad overview of the different therapeutic options for the management of localized or metastatic UM disease, with recently updated data.
The Melanoma Focus Uveal Melanoma guideline was begun in 2012 and published in 2015. In 2020 a review and update of this guideline was initiated which was completed in 2022.
Patient selection criteria included diagnosis of uveal melanoma from April 1, 2001, to April 1, 2011, adequate records to allow tumor staging by the AJCC criteria, and follow-up for metastatic melanoma.
The NCCN Guidelines Panel for Melanoma debuted new guidelines for uveal melanoma at the NCCN 23rd Annual Conference. Although uveal melanoma and cutaneous melanoma share the same name, they do have different characteristics and treatments. The NCCN Guide-lines describe how tumor size guides therapeutic options, which for most tumors is ...
